Novo Nordisk aims to launch more than five blockbuster drugs by 2030, CEO says
来源：Reuters发布于 2026-09-21
Novo Nordisk aims to launch more than five blockbuster drugs by 2030 and to deliver more than 150 billion Danish crowns ($23 billion) in pipeline sales in 2035, its CEO Mike Doustdar said at its Cap...
相关标的：NVO
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。